HomeResearchPublicationsPoster Presentations

  1. Can F, Azap O.K, Dolapci I, Yesilkaya A , Arslan H, Ergonul O. Host Risk Factors and Efflux Pump Gene Expressions Among E.coli Strains Isolated From Community Acquired Urinary Tract Infections. 52th ICAAC, San Francisco, 2012.
  2. Can F, Azap O.K, Dolapci I, Yesilkaya A , Arslan H, Ergonul O. Predictors of efflux pumps and topoisomerase mutations in E.coli  ısolates ın communıty acquıred urınary tract ınfectıon. 53th ICAAC, Denver, 2013.
  3. Can F, Azap O.K, Seref C, Ispir P, Arslan H, Ergonul O. Emergence of E.coli O25b-ST131 clone among uropathogenİc multi drug resistant isolates and associated clinical risk factors. 24th ECCMID, 1976, BarcelonA, 2014
  4. Ergonul O, Donmez E, Ispır P, Seref C, Can F. The critical role of molecular surveillance in control of Acinetobacter baumannii infections. 24th ECCMID, 3128, BarcelonA, 2014
  5. Can F, Azap O, Seref C, Ispir P, Ergonul O. Virulence characteristics of E.coli O25b/ST131 strains isolated from patients with bacteremia. 54th ICAAC, Washington DC, 2014.
  6. Nurtop E, Can F, Bayindir Bilman F, Kurt Azap O, Ergonul O. Molecular Mechanisms of Colistin Resistance in Clinical’Isolates of Acinetobacter baumannii. 55th ICAAC, San Diego, 2015
  7.  Ispir P, Can F, Menekse S, Lack N, Azap O, Timurkaynak F, Ergonul O. Clinical and Molecular Factors Effecting Colistin Resistance in Klebsiella pneumonia. 55th ICAAC, San Diego, 2015.
  8. Dilem Oran , Tolga Lokumcu , Ozgur Albayrak , Tugba Bal , Tugba Bagci-Onder, Mert Erkan, Can F, Design of Local Immune-Privileged Microenvironment to Prevent Islet Graft Rejection, Biomedical Engineering Society (BMES) Annual Meeting 2017, Oct,:2016,Texas, ABD
  9. S. Keske, F. Tutucu, D. Karaaslan, F. Can, E. Nurtop, P. Ispir, E. Palaoglu, Ö. Ergönül, Viral respiratory infections: the impact of rapid molecular diagnostic tests on antimicrobial stewardship, 27th ECCMID Congress, Vienna, 2017.
  10.  Ataç N., Can F. Overexpression of efflux pump genes in quinolone resistant E.coli ST131. 3rd COST Action IPROMEDAI meeting, Oct, 2016, Samos, Greece
  11. Ataç N., Can F. Novel therapy approaches for E.coli ST131 infections. XIX. KLIMIK Congress, 2018, Antalya
  12. Akartuna C, Yalçin CE, Kapmaz M, Can F, Gargili A, Ergönül Ö. Lyme in Turkey: underestimated or over-diagnosed? ECCMID 2018, 21-24 April, Madrid.
  13. Atac N., Albayrak O., Ozer B., Vatansever C., Dogan O., Tekin S., Can F., Ergonul O. “Comparison of two different biofilm assessment methods in Candida parapsilosis candidemia isolates. XX. KLIMIK Congress, 2019, Antalya
  14. Doğan Ö., Ataç N., Vatansever C., Albayrak Ö., Şahin E.Ö., Kılıçoğlu K.B., Demiray A., Ergonul O., Gönen M., Can F. Yersiniabactin as a Promoter of Mortality of Infections Caused by Colistin-Resistant Klebsiella pneumoniae ST101. 29th ECCMID. 2019, Amsterdam
  15. Doğan Ö., Menekşe Ş., Yeşilkaya A., Karakoç Ç., Ataç N., Albayrak Ö., Tekin S., Keske S., Aydın M., Yalçın D., Aksu ED., Can F., Ergonul O.  Predictors of fatality among the patients with blood stream infections with different Candida species and resistance to antifungal agents: a multicenter prospective observational study of the Turkish Fungal Infections Study Group. 29th ECCMID. 2019, Amsterdam
  16. Atac, N. Bilici, K. Muti, A. Acar-Yagci, F. Sennaroğlu, A. Can, F. FimH Targeted SPIONs for treatment of E.coli ST131. 29th ECCMID. 2019, Amsterdam
  17. Albayrak Ö., Atac N., Vatansever C., Ozer B., Dogan O., Kılıçoğlu K.B., Demiray A., Şahin E.Ö., Can F. The Role of Yersiniabactin Siderophore on Survival of High-Risk Clone of Klebsiella pneumoniae after Phagocytosis and NETosis”. 13rd World Immune Regulation Meeting. 2019, Davos